Literature DB >> 17108687

Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease.

Yvonne Davidson1, Linda Gibbons, Antonia Pritchard, Jayne Hardicre, Joanne Wren, Cheryl Stopford, Camille Julien, Jennifer Thompson, Antony Payton, Stuart M Pickering-Brown, Neil Pendleton, Michael A Horan, Alistair Burns, Nitin Purandare, Corinne L Lendon, David Neary, Julie S Snowden, David M A Mann.   

Abstract

The age distribution of the epsilon4 allelic form of the apolipoprotein E gene (APOE) was investigated in 630 patients with Alzheimer's disease (AD) with onset age ranging from 35 to 90 years. Overall, mean age at onset in APOE epsilon4 allele bearers was significantly later than that in nonbearers. However, when stratified into early onset AD (EOAD) and late onset (LOAD) groups, mean age at onset in EOAD cases bearing APOE epsilon4 allele was later than that in those EOAD cases without epsilon4 allele, whereas in LOAD mean age at onset in cases bearing APOE epsilon4 allele was earlier than in those without epsilon4 allele. When analysed by decade, it was observed that 37% of the total number of APOE epsilon4 allele bearers, and 43% of total number of cases with APOE epsilon4/epsilon4 genotype fell into the 60-69 years age class. Hence, APOE epsilon4 allele frequency, at 0.44, was highest in the 60-69 years age class, progressively decreasing either side of this age group. APOE epsilon4 allele therefore has its maximum impact between onset ages of between 60 and 70 years. Copyright 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108687     DOI: 10.1159/000097038

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  18 in total

1.  Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease.

Authors:  Vincenzo De Luca; Maria Donata Orfei; Sara Gaudenzi; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-12-29       Impact factor: 5.270

2.  Interactions between life stress factors and carrying the APOE4 allele adversely impact self-reported health in old adults.

Authors:  Yi Zeng; Claude L Hughes; Megan A Lewis; Jianxin Li; Fengyu Zhang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

3.  Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease.

Authors:  Edmond Teng; Tritia R Yamasaki; Michelle Tran; Julia J Hsiao; David L Sultzer; Mario F Mendez
Journal:  Dement Geriatr Cogn Disord       Date:  2013-12-31       Impact factor: 2.959

4.  Age-related differences in white matter integrity and cognitive function are related to APOE status.

Authors:  Lee Ryan; Katrin Walther; Barbara B Bendlin; Lih-Fen Lue; Douglas G Walker; Elizabeth L Glisky
Journal:  Neuroimage       Date:  2010-09-06       Impact factor: 6.556

Review 5.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

6.  The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia.

Authors:  Marianna Trebunová; Eva Slabá; Viera Habalová; Zuzana Gdovinová
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

7.  Neuronal fiber bundle lengths in healthy adult carriers of the ApoE4 allele: a quantitative tractography DTI study.

Authors:  Lauren E Salminen; Peter R Schofield; Elizabeth M Lane; Jodi M Heaps; Kerrie D Pierce; Ryan Cabeen; David H Laidlaw; Erbil Akbudak; Thomas E Conturo; Stephen Correia; Robert H Paul
Journal:  Brain Imaging Behav       Date:  2013-09       Impact factor: 3.978

Review 8.  Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.

Authors:  Mario F Mendez
Journal:  Arch Med Res       Date:  2012-11-21       Impact factor: 2.235

9.  Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk.

Authors:  Christopher R Simmons; Fanggeng Zou; Steven G Younkin; Steven Estus
Journal:  Mol Neurodegener       Date:  2011-08-25       Impact factor: 14.195

10.  Perilla Seed Oil Enhances Cognitive Function and Mental Health in Healthy Elderly Japanese Individuals by Enhancing the Biological Antioxidant Potential.

Authors:  Michio Hashimoto; Kentaro Matsuzaki; Shahdat Hossain; Tomoko Ito; Harumi Wakatsuki; Yoko Tanabe; Miho Ohno; Setsushi Kato; Kazuya Yamashita; Osamu Shido
Journal:  Foods       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.